Emerald Health Therapeutics (EMHTF) Return on Equity ROE from the fourth quarter 2019 to fourth quarter 2018 and annually, average high and low, overall ranking from Dec 31 2019 to Dec 31 2018 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Emerald Health Therapeutics Inc.  (EMHTF)

Emerald Health Therapeutics's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Emerald Health Therapeutics in the fourth quarter 2019?
Emerald Health Therapeutics Inc. achieved a return on average equity (ROE) of 341.31 % in its fourth quarter 2019, this is above EMHTF's average return on equity of -105.97%.
Emerald Health Therapeutics Inc. shareholder's equity over the 12 months ending in its fourth quarter 2019 are valued at $20 million

ROE has advanced compared to 23.45% in the third quarter 2019, due to net income growth.

Within the Major Pharmaceutical Preparations industry 254 other companies had a higher return on equity. While the total ranking for ROE unchanged, relative to the third quarter 2019 at no. .

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2019)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2018)
IV. Quarter
Y / Y Equity Change -36.31 % 88.34 % 88.34 % 88.34 % -
Y / Y Net Income Change 261.18 % - - - -
Net Income (TTM) in Millions 69 7 16 12 10
Return On Equity (TTM) 341.31 % 23.45 % 49.77 % 37.17 % 33.3 %
EMHTF's Total Ranking # # # # #
Equity (TTM) in Millions 80 1 1 1 125
Seq. Equity Change 13471.19 % 0 % 0 % -99.53 % 40030.36 %
Seq. Net Income Change - - - - -

Back to EMHTF Management Effectiveness >> EMHTF's 5 Years Annual ROE >> Compare EMHTF ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 255
Sector # 527
Overall #

Return On Equity Statistics
High Average Low
-105.97 %
-105.97 %
-105.97 %
(Dec 31 2019)  





EMHTF Annual Return On Equity (Dec 31 2019)
2019		 (Dec 31 2018)
2018


Total Equity in Millions 80 125 0 0 0
Y / Y Equity Change -36.31 % - - - -
Net Income in Millions -84 -24 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity -105.97 % -19.15 % - - -

Back to EMHTF Management Effectiveness >> EMHTF's 5 Years Annual ROE >> Compare EMHTF ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
EMHTF's' Return on Equity at Yahoo Finance
EMHTF's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for EMHTF's Competitors
Subscribers only: Roe for Emerald Health Therapeutics's Suppliers
Subscribers only: Return On Equity for EMHTF's Customers




Companies with similar Return On Equity at Dec 31 2019, within Healthcare Sector ROE
Zomedica Corp   611.96 %
Tuhura Biosciences Inc   497.74 %
Lexicon Pharmaceuticals Inc   303.98 %
Coherus Oncology inc   302.63 %
Xbiotech Inc   288.62 %
Eli Lilly And Company  287.25 %
Idexx Laboratories Inc  283.32 %
Quoin Pharmaceuticals Ltd   232.48 %
Aveo Pharmaceuticals Inc   225.40 %
Check Cap Ltd  221.94 %
Morphic Holding inc   212.35 %
Waters Corporation  166.44 %
Semler Scientific inc   152.53 %
Integrated Biopharma Inc  138.15 %
Nrc Health  117.23 %
Mettler toledo International Inc   116.60 %
Tenax Therapeutics Inc   114.72 %
Altamira Therapeutics Ltd   107.01 %
Orgenesis Inc   84.68 %
Jounce Therapeutics inc   82.61 %
Biomx Inc  81.49 %
Molecular Templates Inc   81.33 %
Amgen Inc   74.29 %
Innoviva Inc   71.23 %
Castle Biosciences Inc   69.30 %

Date modified: 2026-10-15T05:23:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.